Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2011

Quarterly Financial Data [Abstract]

Schedule Of Quarterly Financial Data

(in thousands, except per share amounts)	First Quarter		Second Quarter			Third Quarter			Fourth Quarter
Fiscal Year 2011:
Net sales	$	1,375,513	$	1,446,751		$	1,382,558		$	1,406,874
Gross profit		1,011,071		1,051,828	(a)		1,012,443	(c)	$	1,004,143	(e)
Net earnings		233,428		240,894	(b)		226,472	(d)	$	124,999	(f)
Basic net earnings per share	$	0.72	$	0.73		$	0.70		$	0.39
Diluted net earnings per share	$	0.71	$	0.72		$	0.69		$	0.39
Fiscal Year 2010:
Net sales	$	1,261,696	$	1,312,769		$	1,239,905		$	1,350,401
Gross profit		940,527		967,467			900,086			946,580	(h)
Net earnings		238,569		254,038			208,385	(g)		206,444	(i)
Basic net earnings per share	$	0.73	$	0.78		$	0.63		$	0.62
Diluted net earnings per share	$	0.73	$	0.77		$	0.63		$	0.62

(a)	Includes pre-tax special charges of $11.0 million associated with restructuring activities to realign certain activities in the Company's CRM business.
(b)	Includes after-tax special charges of $29.0 million associated with restructuring activities to realign certain activities in the Company's CRM business and after-tax IPR&D charges of $2.8 million associated with the Company's acquisition of certain pre-development technology assets.
(c)	Includes pre-tax special charges of $7.2 million associated with restructuring actions to realign certain activities in our CRM business and our sales and selling support organizations.

(d)	Includes after-tax special charges of $20.9 million related to restructuring actions to realign certain activities in our CRM business and our sales and selling support organizations.
(e)	Includes pre-tax special charges of $29.3 million associated with restructuring actions to realign certain activities in our CRM business and our sales and selling support organizations.
(f)	Includes after-tax special charges of $71.0 million related to restructuring actions to realign certain activities in our CRM business and our sales and selling support organizations, after-tax special charges of $30.4 million for intangible asset impairment charges and $38.4 million of after-tax accounts receivable allowance charges for collection risk in Europe.
(g)	Includes after-tax IPR&D charges of $12.2 million related to the Company's purchase of certain pre-development technology assets.
(h)	Includes pre-tax special charges of $27.9 million primarily related to inventory obsolescence charges resulting from excess ICD inventory.
(i)	Includes after-tax special charges of $17.4 million primarily related to inventory obsolescence charges resulting from excess ICD inventory; after-tax special charges of $15.3 million in connection with the settlement of a U.S. Department of Justice investigation; and an after-tax impairment charge of $5.2 million related to a cost method investment deemed to be other-than-temporarily impaired. Partially offsetting these after-tax charges is a $19.7 million income tax benefit related to the federal research and development tax credit extended in the fourth quarter of 2010 retroactive to the beginning of the year.